AI Terminal
Crushmetric Group Limited
Share Issue/Capital Change • Dec 31, 2020
10335_rns_2020-12-31_643bad79-a231-446b-9273-bb15149561cc.html
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 3160K
MiLOC Group Limited
31 December 2020
31 December 2020
MiLOC GROUP LIMITED
("MiLOC" or "the Company")
TERMINATION OF ENDORSEMENT AGREEMENT
MiLOC announces that its wholly owned subsidiary, MiLOC Pharmaceutical (HK) Limited ("MPHK"), has entered into a termination of the endorsement agreement with BrandKing Worldwide Limited and First Strong Workshop Limited for the AKFS+ haircare products which was signed on 1st July 2016. MPHK has also entered into a termination of the commission agreement which was signed with CN Workshop Limited together with the endorsement agreement on 1st July 2016.
The Company is renegotiating the termination settlement amount which is due on 31 December 2020.
A further announcement will be made once the termination settlement amount is paid.
The directors of the Company accept responsibility for the contents of this announcement.
For further information, please contact:-
| MiLOC ONG Ban Poh Michael - Chief Executive Officer Ronnie CHOI - Chief Financial Officer |
Tel: +852 2110 4221 |
| AQSE Growth Market Corporate Adviser PETERHOUSE CAPITAL LIMITED Guy Miller Mark Anwyl |
Tel: +44 (0) 20 7469 0930 |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NEXFFLFXBLLZFBK